Comparison of Liver Transplant Outcomes in Biliary Atresia Patients, Considering Whether They Underwent the Kasai Procedure Beforehand: A Single Center Analysis of 72 Patients

Transplant Proc. 2023 Jun;55(5):1199-1208. doi: 10.1016/j.transproceed.2023.04.034. Epub 2023 Jun 10.

Abstract

Background: This study examines the results of liver transplantation (LT) in patients with biliary atresia, considering whether they underwent the Kasai procedure beforehand. LT and determine postoperative and long-term graft outcomes.

Methods: This single-center, retrospective study included 72 pediatric patients diagnosed with postpartum biliary atresia who underwent LT between 2010 and 2022. We included patients who underwent LT either after or without the Kasai procedure and compared the demographic data of the patients with various factors, such as the Pediatric End-Stage Liver Disease scores and laboratory values.

Results: The study included 72 patients, with 39 of them being female (54.2%) and 33 of them being male (45.8%). Of the 72 patients in the study, 47 (65.3%) had undergone the Kasai procedure, and 25 (34.7%) had not. The preoperative and postoperative month 1 bilirubin values were lower in patients who underwent the Kasai procedure and were higher in postoperative months 3 and 6. Preoperative bilirubin values, postoperative month 3 bilirubin values, and preoperative albumin values were higher in patients who developed mortality (P < .05). Cold ischemia time was longer in patients who developed mortality (P < .05).

Conclusions: Our study showed a higher mortality rate in patients who underwent the Kasai procedure. The results also showed that LT was more effective in children, as patients with Kasai had higher mean bilirubin values and higher preoperative albumin values than patients without Kasai.

MeSH terms

  • Biliary Atresia* / surgery
  • Bilirubin
  • Child
  • End Stage Liver Disease* / etiology
  • Female
  • Humans
  • Infant
  • Liver Transplantation* / methods
  • Male
  • Portoenterostomy, Hepatic / adverse effects
  • Portoenterostomy, Hepatic / methods
  • Retrospective Studies
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Bilirubin